Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study

Summary

This study has been designed to collect long-term follow-up information for patients who received REGN2810 in other clinical studies and to allow re-treatment for eligible patients.

Timeline

Start

2015-08

Primary completion

2023-11

Completion

2023-11

Drugs

Indications